肥胖多囊卵巢综合征女性的孕激素受体与子宫内膜增殖——一项生活方式干预研究
该研究纳入20例肥胖多囊卵巢综合征(PCOS)女性和10例年龄及体重指数匹配的规律月经对照,采用横断面研究与生活方式干预(饮食管理和体育锻炼),评估子宫内膜孕激素受体(PRA、PRB、PGRMC1、PGRMC2)mRNA及免疫染色与增殖标志物Ki67的关系。结果显示生活方式干预后PRB mRNA下降至与对照无差异,但PRAB mRNA仍低,分泌期子宫内膜增殖下降但未完全恢复。
要点
- PCOS组增殖期子宫内膜PRAB mRNA低于对照而PRB mRNA高于对照(P < 0.05)。
- 生活方式干预减重后PRB mRNA下降至与对照无差异(P < 0.01),PRAB mRNA仍低。
- 持续无排卵PCOS亚组周期第21至23天PRB、PGRMC1、PGRMC2及Ki67蛋白水平高于对照(P < 0.05)。
核心结论
- 生活方式干预改善但未完全恢复肥胖PCOS女性的孕激素受体表达,并降低分泌期子宫内膜的增殖。
研究设计与样本
- 横断面研究及生活方式干预,纳入20例肥胖PCOS女性和10例年龄及体重指数匹配的规律月经对照。
- 干预为饮食管理和体育锻炼。
- 主要结局指标为子宫内膜PRs(PRA、PRB)、PGRMC1、PGRMC2的mRNA水平与免疫染色及增殖标志物Ki67。
主要发现
- 生活方式干预前,肥胖PCOS女性增殖期子宫内膜PRAB mRNA表达低于对照而PRB mRNA表达高于对照(P < 0.05)。
- 生活方式干预减重后,增殖期子宫内膜PRAB mRNA仍低,但PRB mRNA下降至与对照无差异(P < 0.01)。
- 持续无排卵的PCOS亚组周期第21至23天PRB、PGRMC1、PGRMC2及Ki67蛋白水平高于对照(P < 0.05)。
- 确认排卵的PCOS亚组分泌期子宫内膜免疫染色(包括Ki67)与对照无差异,但PRA较高(P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS) is associated with increased risk of endometrial cancer. This is usually explained by chronic anovulation and deficient progesterone activity. However, the role of progesterone receptors (PRs) in endometrial proliferation is unclear. OBJECTIVE: To evaluate PRs in relation to endometrial proliferation in women with PCOS. DESIGN: Cross-sectional study and lifestyle intervention. SETTING: Clinical and laboratory research unit at a university hospital. PARTICIPANTS: Twenty obese women with PCOS and 10 age- and body mass index-matched regularly menstruating controls. INTERVENTION: Dietary management and physical exercise. MAIN OUTCOME MEASURES: Endometrial messenger RNA (mRNA) levels and immunostaining of the nuclear PRs A (PRA) and B (PRB), nongenomic progesterone receptor membrane component 1 (PGRMC1) and 2 (PGRMC2), and proliferation marker Ki67. RESULTS: Before lifestyle intervention, mRNA expression of PRAB was lower while PRB was higher in proliferative endometrium of obese women with PCOS compared with controls (P < 0.05). After lifestyle intervention and weight loss, mRNA expression of PRAB was still low but PRB mRNA decreased and was not different to controls in proliferative endometrium (P < 0.01). The subgroup of PCOS women who remained anovulatory displayed higher protein levels of PRB, PGRMC1, PGRMC2 and of the proliferative marker Ki67 on cycle days 21 to 23 than controls (P < 0.05). In contrast, the subgroup of PCOS women with confirmed ovulation showed immunostaining, including Ki67, in secretory endometrium that was not different to controls, except for higher PRA (P < 0.05). CONCLUSIONS: Lifestyle intervention improves, but not fully restores PR expression and decreases proliferation in secretory endometrium of obese PCOS women.
引用
- Paulson M, Sahlin L, Hirschberg AL, et al. Progesterone Receptors and Proliferation of the Endometrium in Obese Women With Polycystic Ovary Syndrome-A Lifestyle Intervention Study. J Clin Endocrinol Metab. 2017. PMID: 28388727. doi:10.1210/jc.2016-3155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。